Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-18

FDA Approved: VIGABATRIN — Supplemental Application (Cipla USA, Inc.)

View source ↗

Summary

The FDA approved Cipla USA, Inc.'s supplemental application for Vigabatrin, resulting in an approved change to the labeling for the product. This action represe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)